Canada Pulls Controversial Pricing Measures
Executive Summary
Some measures aimed at reducing medicine prices in Canada have been dropped, to the relief of the pharmaceutical industry.
You may also be interested in...
COVID-19 Pandemic Means Another Delay For Canadian Pricing Reforms
Industry has have welcomed another delay to the implementation of drug pricing reforms that aim to lower Canadian drugs prices.
Canadian Drug Pricing Reforms Could Lead To Medicine Shortages
Drug pricing reform in Canada could prompt companies to launch elsewhere or see drugs diverted to the US.
England’s Innovative Medicines Fund To Put Spotlight On Rare Disease Treatments
While the much-anticipated Innovative Medicines Fund is likely to benefit rare diseases in particular, other products must gain too.